Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The BMDI Cord Blood Bank (CBB) is a leading public cord blood bank based in Melbourne, Australia, and a key member of the AusCord national network. Established in 1996, it is operated by a consortium comprising the Royal Children's Hospital, the Fight Cancer Foundation, and the Murdoch Children's Research Institute (MCRI). The bank specializes in the collection, processing, and cryopreservation of umbilical cord blood units for life-saving hematopoietic stem cell transplants in patients with leukemia and other blood disorders. Beyond its primary banking operations, BMDI CBB serves as a research hub for advanced cellular therapies, including the development of clinical-grade induced pluripotent stem cell (iPSC) lines and the investigation of cord blood-derived treatments for regenerative medicine applications such as osteoarthritis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BDMI Cord Blood Bank.